Literature DB >> 19802543

Protective effect of effective composite of Chinese medicine prescription naodesheng against focal cerebral ischemia in rats.

Li Zhang1, Xin-rui Cheng, Ruo-yun Chen, Xiao-ming Zhu, Guan-hua Du.   

Abstract

OBJECTIVE: To study the effects and possible mechanisms of effective composite of Naodesheng (NDS) on permanent cerebral ischemia-induced injury in rats.
METHODS: Male Sprague-Dawley rats: with middle cerebral artery occlusion (MCAO) were established with the modified suture method, and they were randomly divided into the following groups: the sham-operated group, the model group, the Nimodipine group (0.012 g/kg), the NDS group (1.075 g/kg), the total extracts group (0.23 g/kg), the high-dose NEC group (0.07 g/kg), the middle-dose NEC group (0.02 g/kg), and the low-dose NEC group (0.007 g/kg). The aforesaid medicines were administered at the 2nd, 4th, and 24th h after focal cerebral ischemia, and the infarction size and water content in the brain were evaluated at the 26th h after MCAO. Then, after oral administration once daily for 7 successive days, the changes in the degree of neurological deficit, oxidative stress, and apoptosis were measured on the 7th day.
RESULTS: NEC could significantly reduce the infarction size after focal cerebral ischemia, and slightly relieve water content in the brain, significantly alleviate neurological function impairment, increase the levels of superoxide dismutase (SOD) and adenosine triphosphate enzyme (ATPase) activity, and decrease the content of malondialdehyde (MDA). NEC could also extenuate Bax and caspase-3 expression in the hippocampus tissue of the ischemic region. As compared with the three NEC treated groups, the high-dose NEC showed better efficacy.
CONCLUSIONS: NEC could significantly reduce brain injury induced by ischemia;: its mechanism was closely associated with hindering oxidative stress and apoptosis. The effective composite-guided methodology is a feasible tool to improve the neuro-protective properties of the Chinese medicine guided prescription NDS against focal cerebral ischemia in rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19802543     DOI: 10.1007/s11655-009-0377-4

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  14 in total

Review 1.  Role of oxidants in ischemic brain damage.

Authors:  P H Chan
Journal:  Stroke       Date:  1996-06       Impact factor: 7.914

2.  The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways.

Authors:  Qiu-Hua Guan; Dong-Sheng Pei; Quan-Guang Zhang; Zhi-Bin Hao; Tian-Le Xu; Guang-Yi Zhang
Journal:  Brain Res       Date:  2005-02-21       Impact factor: 3.252

3.  Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

Authors:  L Belayev; O F Alonso; R Busto; W Zhao; M D Ginsberg
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

4.  Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.

Authors:  Y Yang; Q Li; H Miyashita; W Howlett; M Siddiqui; A Shuaib
Journal:  J Neurosurg       Date:  2000-05       Impact factor: 5.115

5.  Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia.

Authors:  J Chen; S H Graham; M Nakayama; R L Zhu; K Jin; R A Stetler; R P Simon
Journal:  J Cereb Blood Flow Metab       Date:  1997-01       Impact factor: 6.200

6.  Depletion of circulating alpha(2)-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization.

Authors:  N Nagai; M De Mol; B Van Hoef; M Verstreken; D Collen
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method.

Authors:  Y Yang; A Shuaib; Q Li
Journal:  J Neurosci Methods       Date:  1998-10-01       Impact factor: 2.390

8.  A critical role of neural-specific JNK3 for ischemic apoptosis.

Authors:  Chia-Yi Kuan; Alan J Whitmarsh; Derek D Yang; Guanghong Liao; Aryn J Schloemer; Chen Dong; Jue Bao; Kenneth J Banasiak; Gabriel G Haddad; Richard A Flavell; Roger J Davis; Pasko Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

9.  Different expression patterns of Bcl-2, Bcl-xl, and Bax proteins after sublethal forebrain ischemia in C57Black/Crj6 mouse striatum.

Authors:  Chaoran Wu; Hideyoshi Fujihara; Jian Yao; Sihua Qi; Huiping Li; Koki Shimoji; Hiroshi Baba
Journal:  Stroke       Date:  2003-06-05       Impact factor: 7.914

10.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

Authors:  J B Bederson; L H Pitts; S M Germano; M C Nishimura; R L Davis; H M Bartkowski
Journal:  Stroke       Date:  1986 Nov-Dec       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.